Core Insights - VinFast Auto Ltd. reported a quarterly loss of $0.41 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.25, marking a 64% earnings surprise [1] - The company generated revenues of $718.63 million for the quarter ended September 2025, missing the consensus estimate by 12.66%, but showing an increase from $511.62 million year-over-year [2] - The stock has underperformed, losing about 14% since the beginning of the year compared to the S&P 500's gain of 11.2% [3] Financial Performance - Over the last four quarters, VinFast has not surpassed consensus EPS estimates, with only one instance of exceeding revenue estimates [2] - The current consensus EPS estimate for the upcoming quarter is -$0.23 on revenues of $1.04 billion, and for the current fiscal year, it is -$1.21 on revenues of $3.23 billion [7] Market Outlook - The company's earnings outlook and management commentary will be crucial for future stock performance [4] - The Zacks Rank for VinFast is currently 3 (Hold), indicating expected performance in line with the market [6] - The Automotive - Domestic industry is ranked in the top 39% of Zacks industries, suggesting a favorable environment for stocks in this sector [8]

Core Insights - Oddity Tech reported quarterly earnings of $0.4 per share, exceeding the Zacks Consensus Estimate of $0.35 per share, and showing an increase from $0.32 per share a year ago, resulting in an earnings surprise of +14.29% [1] - The company achieved revenues of $147.9 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.27% and up from $119 million year-over-year [2] Financial Performance - Over the last four quarters, Oddity Tech has consistently surpassed consensus EPS estimates [2] - The company has also topped consensus revenue estimates four times in the last four quarters [2] - The current consensus EPS estimate for the upcoming quarter is $0.14 on revenues of $149.14 million, and for the current fiscal year, it is $2.09 on revenues of $804.41 million [7] Market Position - Oddity Tech shares have underperformed the market, losing about 13% since the beginning of the year, while the S&P 500 has gained 12.5% [3] - The Zacks Rank for Oddity Tech is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Internet - Software industry, to which Oddity Tech belongs, is currently ranked in the top 24% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - LifeMD, Inc. reported a quarterly loss of $0.1 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.06, representing an earnings surprise of -66.67% [1] - The company posted revenues of $60.17 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 3.42%, but showing an increase from $53.39 million year-over-year [2] - LifeMD shares have declined approximately 6.5% year-to-date, contrasting with the S&P 500's gain of 14.5% [3] Financial Performance - Over the last four quarters, LifeMD has surpassed consensus EPS estimates two times [2] - The current consensus EPS estimate for the upcoming quarter is -$0.05 on revenues of $62.85 million, and for the current fiscal year, it is -$0.15 on revenues of $253.06 million [7] Market Outlook - The company's earnings outlook is mixed, with a Zacks Rank of 3 (Hold), indicating expected performance in line with the market [6] - The Medical Services industry, to which LifeMD belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, suggesting potential challenges ahead [8] Comparisons with Peers - HealthEquity, another company in the same industry, is expected to report quarterly earnings of $0.90 per share, reflecting a year-over-year increase of 15.4% [9] - HealthEquity's anticipated revenues are $319.96 million, which is a 6.5% increase from the previous year [10]

分组1 - Actelis Networks reported a quarterly loss of $0.17 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.13, and compared to a loss of $0.09 per share a year ago, indicating a significant earnings surprise of -30.77% [1] - The company posted revenues of $0.64 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 57.13%, and a decline from year-ago revenues of $2.54 million [2] - Actelis Networks shares have declined approximately 68% since the beginning of the year, contrasting sharply with the S&P 500's gain of 14.6% [3] 分组2 - The earnings outlook for Actelis Networks is uncertain, with current consensus EPS estimates at -$0.09 on $2 million in revenues for the coming quarter and -$0.64 on $5.16 million in revenues for the current fiscal year [7] - The Zacks Industry Rank for Communication - Components is currently in the top 15% of over 250 Zacks industries, suggesting that the industry outlook can significantly impact stock performance [8] - The estimate revisions trend for Actelis Networks was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]

分组1 - CG Oncology, Inc. reported a quarterly loss of $0.57 per share, consistent with the Zacks Consensus Estimate, compared to a loss of $0.30 per share a year ago [1] - The company posted revenues of $1.67 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 412.62%, and up from $0.04 million year-over-year [2] - CG Oncology's shares have increased approximately 31.7% since the beginning of the year, outperforming the S&P 500's gain of 14.6% [3] 分组2 - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The trend for estimate revisions for CG Oncology was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] - The current consensus EPS estimate for the upcoming quarter is -$0.59 on revenues of $3.37 million, and for the current fiscal year, it is -$2.15 on revenues of $2.74 million [7] 分组3 - The Medical - Biomedical and Genetics industry, to which CG Oncology belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Core Insights - Owlet, Inc. reported quarterly earnings of $0.03 per share, exceeding the Zacks Consensus Estimate of a loss of $0.23 per share, marking an earnings surprise of +113.04% [1] - The company generated revenues of $32 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 20.53% and showing an increase from $22.1 million year-over-year [2] - Owlet shares have appreciated approximately 147.2% year-to-date, significantly outperforming the S&P 500's gain of 16.5% [3] Earnings Performance - Over the last four quarters, Owlet has exceeded consensus EPS estimates three times [2] - The company had a previous expectation of a loss of $0.21 per share but reported a smaller loss of $0.05, resulting in a surprise of +76.19% [1] Future Outlook - The sustainability of Owlet's stock price movement will largely depend on management's commentary during the earnings call [3] - Current consensus EPS estimate for the upcoming quarter is -$0.26 on revenues of $24.58 million, and for the current fiscal year, it is -$5.38 on revenues of $98.33 million [7] Industry Context - The Technology Services industry, to which Owlet belongs, is currently ranked in the top 27% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Owlet's performance [5]

Core Insights - Nyxoah SA reported a quarterly loss of $0.74 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.61, and compared to a loss of $0.55 per share a year ago, indicating a significant earnings surprise of -21.31% [1] - The company generated revenues of $2.31 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 18.02%, and showing an increase from $1.39 million in the same quarter last year [2] - Nyxoah shares have declined approximately 26.4% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Financial Performance - Over the last four quarters, Nyxoah has only surpassed consensus EPS estimates once [2] - The current consensus EPS estimate for the upcoming quarter is -$0.58 on revenues of $3.59 million, and for the current fiscal year, it is -$2.52 on revenues of $8.34 million [7] Market Outlook - The estimate revisions trend for Nyxoah was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell), suggesting expected underperformance in the near future [6] - The outlook for the Medical Info Systems industry, where Nyxoah operates, is currently in the top 30% of over 250 Zacks industries, indicating a favorable environment that could impact stock performance positively [8]

Core Insights - Legacy Education Inc. reported quarterly earnings of $0.16 per share, exceeding the Zacks Consensus Estimate of $0.15 per share, but down from $0.21 per share a year ago, indicating an earnings surprise of +6.67% [1] - The company achieved revenues of $19.4 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.79% and up from $14.01 million year-over-year [2] - Legacy Education Inc. has outperformed consensus EPS estimates three times over the last four quarters and has topped consensus revenue estimates four times in the same period [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.13 on revenues of $18.05 million, while the estimate for the current fiscal year is $0.64 on revenues of $75.1 million [7] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Schools industry, to which Legacy Education Inc. belongs, is currently in the top 30% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - Co-Diagnostics, Inc. reported a quarterly loss of $0.16 per share, better than the Zacks Consensus Estimate of a loss of $0.19, and an improvement from a loss of $0.32 per share a year ago, resulting in an earnings surprise of +15.79% [1] - The company posted revenues of $0.15 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 51.67%, and a decline from $0.64 million in the same quarter last year [2] - Co-Diagnostics shares have decreased by approximately 47.2% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Earnings Outlook - The earnings outlook for Co-Diagnostics is uncertain, with current consensus EPS estimates at -$0.16 on $0.3 million in revenues for the upcoming quarter and -$0.79 on $0.81 million in revenues for the current fiscal year [7] - The estimate revisions trend for Co-Diagnostics was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Medical Services industry, to which Co-Diagnostics belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact investor sentiment [5]

分组1 - OneWater Marine reported break-even quarterly earnings per share, compared to a loss of $0.36 per share a year ago, representing an earnings surprise of -100.00% [1] - The company posted revenues of $460.14 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 13.19%, and this is an increase from year-ago revenues of $377.86 million [2] - Over the last four quarters, OneWater Marine has surpassed consensus revenue estimates three times [2] 分组2 - The stock has underperformed the market, losing about 10.8% since the beginning of the year, while the S&P 500 gained 16.5% [3] - The current consensus EPS estimate for the coming quarter is -$0.28 on revenues of $399.5 million, and for the current fiscal year, it is $0.99 on revenues of $1.89 billion [7] - The Zacks Industry Rank for Leisure and Recreation Products is currently in the top 35% of over 250 Zacks industries, indicating a favorable industry outlook [8]